| 2024-06-24 | Sale | 4D Molecular Therapeutics, Inc. FDMT | Chief Executive Officer | 12,930 0.0248% | $23.10 | $298,711 | -5.38% | |
| 2024-02-08 | Sale | 4D Molecular Therapeutics, Inc. FDMT | Chief Executive Officer | 92,001 0.3275% | $27.13 | $2.5M | -1.91% | |
| 2024-01-23 | Sale | 4D Molecular Therapeutics, Inc. FDMT | Chief Executive Officer | 5,696 0.0133% | $18.41 | $104,851 | +42.66% | |
| 2024-01-05 | Sale | 4D Molecular Therapeutics, Inc. FDMT | Chief Executive Officer | 28,237 0.0659% | $19.57 | $552,478 | +32.21% | |
| 2024-01-04 | Sale | 4D Molecular Therapeutics, Inc. FDMT | Chief Executive Officer | 40,732 0.0963% | $20.31 | $827,202 | +28.23% | |
| 2023-12-18 | Sale | 4D Molecular Therapeutics, Inc. FDMT | Chief Executive Officer | 4,702 0.0105% | $18.13 | $85,243 | +34.28% | |
| 2023-12-15 | Sale | 4D Molecular Therapeutics, Inc. FDMT | Chief Executive Officer | 28,632 0.0661% | $17.27 | $494,432 | +47.03% | |
| 2023-02-22 | Sale | 4D Molecular Therapeutics, Inc. FDMT | Chief Executive Officer | 16,449 0.0502% | $20.22 | $332,665 | -14% | |
| 2023-02-21 | Sale | 4D Molecular Therapeutics, Inc. FDMT | Chief Executive Officer | 17,997 0.0572% | $20.96 | $377,209 | -13.62% | |
| 2023-01-20 | Sale | 4D Molecular Therapeutics, Inc. FDMT | Chief Executive Officer | 8,625 0.0262% | $20.19 | $174,127 | -14.18% | |
| 2023-01-19 | Sale | 4D Molecular Therapeutics, Inc. FDMT | Chief Executive Officer | 10,899 0.0333% | $20.03 | $218,347 | -12.72% | |
| 2022-12-16 | Sale | 4D Molecular Therapeutics, Inc. FDMT | Chief Executive Officer | 53,944 0.1646% | $23.02 | $1.24M | -24.88% | |
| 2022-12-15 | Sale | 4D Molecular Therapeutics, Inc. FDMT | Chief Executive Officer | 32,933 0.104% | $23.59 | $776,767 | -23.95% |